Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors

Name: Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors
Creator: Darren Toh
Published: 2024-07-03T00:11:09.810Z
Keywords: Receptor Trafficking, Epidermal Growth Factor Receptor, Tyrosine Kinase Inhibitor, Head and Neck Cancer, Extracellular Vesicle

Toh, Darren; Leong, Hui sun; Chong, Fui Teen; Rodrigues, Dorival Mendes - Junior; Ren, Meng Jie; Kwang, Xue Lin; Lau, Dawn P X; Lee, Po-Hsien; Vettore, Andre Luiz; Teh, Bin Tean; Tan, Daniel S W; Iyer, N Gopalakrishna

doi:10.17632/53wrc86y6s.1

Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors

Published: 3 July 2024| Version 1 | DOI: 10.17632/53wrc86y6s.1

Contributors:

Darren Toh, Hui sun Leong, Fui Teen Chong, Dorival Mendes - Junior Rodrigues, Meng Jie Ren, Xue Lin Kwang, Dawn P X Lau, Po-Hsien Lee, Andre Luiz Vettore, Bin Tean Teh, Daniel S W Tan, N Gopalakrishna Iyer

Description

Supplementary Information for manuscript "Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors".

Files

Institutions

National Cancer Centre Singapore

Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors

Description

Files

Institutions

Categories

Licence